Astrid Zedlitz Johansen

Medicine & Life Sciences

1. Adenocarcinoma 100%
2. Biomarkers 82%
3. Pancreatic Neoplasms 74%
4. Survival 56%
5. Serum 42%
6. Collagen Type III 36%
7. Interleukin-6 34%
8. Tumor Microenvironment 34%
9. Collagen 30%
10. Neoplasms 27%
11. Cancer-Associated Fibroblasts 23%
12. Fibrosis 21%
13. oligochitosan 20%
14. Collagen Type XI 20%
15. C-Reactive Protein 19%
16. Colorectal Neoplasms 19%
17. Biliary Tract Neoplasms 18%
18. Collagen Type V 17%
19. Drug Therapy 17%
20. Galectin 3 15%
21. Peptides 15%
22. Carbohydrates 14%
23. Receptors, Adrenergic, beta 13%
24. Proteins 13%
25. Vitamin D Deficiency 13%
26. Bevacizumab 13%
27. Hyaluronic Acid 12%
28. T-Lymphocytes 12%
29. Fibroblasts 11%
30. Confidence Intervals 11%
31. Vitamin D 11%
32. Growth 10%
33. Macrophages 10%
34. Propranolol 10%
35. Immunosuppressive Agents 9%
36. Vaccination 9%
37. gemcitabine 9%
38. Lung Neoplasms 9%
39. Comorbidity 9%
40. Therapeutics 9%
41. Antigens 9%
42. Collagen Type VI 9%
43. Mortality 8%
44. Area Under Curve 7%
45. In Vitro Techniques 6%
46. Tobacco Smoking 6%
47. Fibrillar Collagens 5%
48. Enzyme-Linked Immunosorbent Assay 5%
49. Pancreatic Diseases 5%